<DOC>
	<DOC>NCT03014661</DOC>
	<brief_summary>Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro</brief_summary>
	<brief_title>Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualit√§t Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen</brief_title>
	<detailed_description>Questionnaire including 19 questions concerning the Quality of life of patients with hayfeyer under or after therapy with a specific immuntherapy with Pollinex quattro</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Pollinosis/seasonal Rhinitis based on an allergy against birch/alder/Hazel pollen OR grass/rye pollen OR mugwort Therapy with Polinex quattro Age &lt;18 years.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pollinosis, quality of life, specific immunotherapy</keyword>
</DOC>